Arnold B. Calmann

Katherine Ann Escanlar

Natalie J. Morgan

Kristina M. Hanson

Emily Shingle

Wendy L. Devine

Bryan C. Diner

Eric J. Marandett

William P. Deni, Jr.

J. Brugh Lower

Bryana T. McGillycuddy

John D. Livingstone

Kenneth Guerra

Stephen R. Donat

Li Zhang

Alexander E. Newkirk

Chiaki Kobayashi

Nao Takada

Shivani Karthikeyan

Kassandra M. Officer

Tanabe Pharma Corp

Azurity Pharmaceuticals Inc

Azurity Pharmaceuticals India LLP

Slayback Pharma LLC

Last Docket Entry Date

Total Docket Entries

Generic NDA filing sparks challenge to RADICAVA ORS®, with infringement allegations over `edaravone particles` in an oral suspension vital for ALS patients.

2:26-cv-00559 | Tanabe Pharma Corp v. Azurity Pharmaceuticals Inc | Ex Parte

United States District of New Jersey

Judge	Period	PO Win Rate
Jennifer Choe-Groves	05/19/26 - now	13%
Claire C. Cecchi	01/20/26 - 05/19/26	74%

Name	Ratings
Finnegan Henderson Farabow Garrett & Dunner LLP	L5B
John D. Livingstone	L5B
Bryan C. Diner	L5E
Kenneth Guerra	---- --
Li Zhang	---- --
Alexander E. Newkirk	---- --
Chiaki Kobayashi	---- --
Shivani Karthikeyan	---- --
Kassandra M. Officer	---- --
FBT Gibbons LLPLocal	L4C
William P. Deni, Jr.	L3E
J. Brugh Lower	L3E
Stephen R. Donat	L1C
Choate Hall & Stewart LLP	L2C
Eric J. Marandett	L5A
Bryana T. McGillycuddy	L4C
Takada LegalLocal	---- --
Nao Takada	---- --

Name	Ratings
Azurity Pharmaceuticals Inc	L3B
Slayback Pharma LLC	L3B
Azurity Pharmaceuticals India LLP	L3B

Name	Ratings
Wilson Sonsini Goodrich & Rosati	L5A
Kristina M. Hanson	L5A
Natalie J. Morgan	L5B
Emily Shingle	---- --
Wendy L. Devine	---- --
SaiberLocal	L3B
Arnold B. Calmann	L4D
Katherine Ann Escanlar	L4E

2:26-cv-00559

Tanabe Pharma Corp v. Azurity Pharma Inc